See the full KLOW cycle-length guide for a comparison of 4-, 6-, 8-12-, and 16-week schedules
Do not use this content to diagnose, treat, or dose yourself.
Safety and Pharmacology Evaluations : Conducting preclinical toxicology, pharmacokinetic, and receptor-binding studies to characterize how AOD 9604 is handled in vivo and confirm it does not activate growth hormone-like proliferative pathways
Unlike HGH, which can lead to muscle growth and other effects on the body, AOD 9604 specifically targets adipose (fat) tissue, promoting fat breakdown while preserving muscle
Self-prescribing high-dose B12 for weight loss purposes is not evidence-based and may delay investigation of underlying health conditions